These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 193145)

  • 1. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 3. [Joint use of aminopropylaminoethylthiophosphate with other radioprotective agents].
    Suroegin EV
    Radiobiologiia; 1980; 20(4):595-8. PubMed ID: 6251511
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
    Brown JM
    Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicity and radiation-protective effect of multi-component combinations of sulfur-containing substances].
    Kalistratov GV; Belavina LP; Zherebchenko PG
    Radiobiologiia; 1982; 22(5):628-32. PubMed ID: 6294725
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute toxicity and radioprotective effectiveness of gammaphos on intramuscular administration to mice].
    Kuna P
    Radiobiologiia; 1985; 25(1):59-62. PubMed ID: 2983365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of APAETP for the prevention of endogenous infection in irradiated rats].
    Mal'tsev VN; Strel'nikov VA; Znamenskiĭ VV; Terekhov AV
    Radiobiologiia; 1979; 19(3):442-4. PubMed ID: 223191
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
    Brown JM
    Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of unusual cell enlargement in the testis of irradiated mouse following treatment with a radioprotective thiophosphate.
    Jaimala ; Bhartiya HC
    Radiobiol Radiother (Berl); 1988; 29(4):429-33. PubMed ID: 2847226
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.
    Kumar S
    Radiobiol Radiother (Berl); 1985; 26(3):359-65. PubMed ID: 2997830
    [No Abstract]   [Full Text] [Related]  

  • 14. [The modification of radiation effect by nucleoside related compounds on a murine tumor given with local radiotherapy and on survival following whole body irradiation].
    Sougawa M; Tanaka Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Oct; 49(10):1298-303. PubMed ID: 2616263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioprotective effect of YM-08310 in radiotherapy of cervical cancer].
    Takahashi M; Abe M; Kawamura T; Iio A; Hamamoto K; Inohara T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):435-42. PubMed ID: 6294593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioprotective phenomena in murine tumors induced by radiosensitizers at high dose levels].
    Shibamoto Y; Ono K; Takahashi M; Abe M; Hori H; Shibata T; Inayana S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 May; 46(5):725-7. PubMed ID: 3763390
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of gammaphos for protecting the brain from delayed radiation damage].
    Shaposhnikova VV; Levitman MKh; Plotnikova ED; Eĭdus LKh
    Radiobiologiia; 1987; 27(1):37-40. PubMed ID: 3029800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
    Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
    Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM; Lemmon MJ
    Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK; Walden TL; Hughes HN; Jackson WE
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.